Knight Capital Group’s Gilead Sciences GILD Stock Holding History

Knight Capital Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$6.88M	Buy	+134,100	New	+$6.99M	0.13%	103

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Knight Capital Group's GILD Position: Q2 2013 in Review

Knight Capital Group opened a new position in Gilead Sciences (GILD) in Q2 2013: 60,678 shares worth $3.11M. The stake represents 0.06% of the portfolio and ranks #317 among its holdings.

948 funds tracked by Wall St. Rank hold GILD as of Q2 2013.

Knight Capital Group held 60,678 shares of Gilead Sciences worth $3.11M as of Q2 2013.
Gilead Sciences was a new Knight Capital Group position in Q2 2013.
Gilead Sciences made up 0.06% of Knight Capital Group's portfolio in Q2 2013, its #317 holding.
948 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.